SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-23-006927
Filing Date
2023-08-09
Accepted
2023-08-08 21:33:37
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2717468
2 filename2.htm EX-10.18 32802
3 filename3.htm EX-10.19 68774
4 filename4.htm EX-10.20 39821
5 filename5.htm EX-10.21 74988
6 GRAPHIC g241143g28u84.jpg GRAPHIC 170268
7 GRAPHIC g241143g37a37.jpg GRAPHIC 109097
8 GRAPHIC g241143g56z79.jpg GRAPHIC 110470
9 GRAPHIC g241143g65g74.jpg GRAPHIC 202991
10 GRAPHIC g241143g73f63.jpg GRAPHIC 86854
11 GRAPHIC g241143g75k94.jpg GRAPHIC 129883
12 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
  Complete submission text file 0000950123-23-006927.txt   4098117
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05663 | Film No.: 231153157
SIC: 2836 Biological Products, (No Diagnostic Substances)